[go: up one dir, main page]

AR105819A1 - Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos - Google Patents

Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos

Info

Publication number
AR105819A1
AR105819A1 ARP160102555A ARP160102555A AR105819A1 AR 105819 A1 AR105819 A1 AR 105819A1 AR P160102555 A ARP160102555 A AR P160102555A AR P160102555 A ARP160102555 A AR P160102555A AR 105819 A1 AR105819 A1 AR 105819A1
Authority
AR
Argentina
Prior art keywords
fcv
vaccine
composition
feline calicivirus
vaccines against
Prior art date
Application number
ARP160102555A
Other languages
English (en)
Inventor
Reynard Frederic
Poulet Herve
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of AR105819A1 publication Critical patent/AR105819A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Vacunas o composiciones contra el FCV. La vacuna o composición puede ser una vacuna o composición que contiene antígenos del FCV. También abarca vectores recombinantes que codifican y expresan antígenos, epítopes o inmunógenos del FCV que se pueden usar en la protección de animales contra una infección por el FCV. Reivindicación 1: Una composición o vacuna, caracterizada porque comprende un antígeno del calicivirus felino (FCV). Reivindicación 2: La composición o vacuna de la reivindicación 1, caracterizada porque el antígeno del FCV forma VLP o cápsides vacías del FCV.
ARP160102555A 2015-08-20 2016-08-19 Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos AR105819A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562207638P 2015-08-20 2015-08-20

Publications (1)

Publication Number Publication Date
AR105819A1 true AR105819A1 (es) 2017-11-15

Family

ID=56740581

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102555A AR105819A1 (es) 2015-08-20 2016-08-19 Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos

Country Status (13)

Country Link
US (1) US10434165B2 (es)
EP (1) EP3337503A1 (es)
KR (1) KR20180041724A (es)
CN (1) CN108135997A (es)
AR (1) AR105819A1 (es)
AU (1) AU2016308630B2 (es)
CA (1) CA2996143A1 (es)
MA (1) MA42653A (es)
MX (1) MX380019B (es)
NZ (1) NZ740551A (es)
PH (1) PH12018500372B1 (es)
UY (1) UY36860A (es)
WO (1) WO2017031120A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025011592A1 (zh) * 2023-07-10 2025-01-16 康希诺(上海)生物研发有限公司 一种用于预防猫疱疹病毒感染的疫苗及其制备方法和用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
EP0173552B1 (en) 1984-08-24 1991-10-09 The Upjohn Company Recombinant dna compounds and the expression of polypeptides such as tpa
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4963481A (en) 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
EP0260148A3 (en) 1986-09-12 1989-06-07 Genentech, Inc. Improved recombinant expression method, vector and transformed cells
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
DE3743138A1 (de) 1987-12-18 1989-09-14 Mayr Christian Gmbh & Co Kg Schleifringlose, elektromagnetische ueberlastkupplung
JP3602530B2 (ja) 1991-03-07 2004-12-15 ヴァイロジェネティクス コーポレイション 遺伝子操作したワクチン菌株
US5846946A (en) 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751225B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
EP0930893B1 (en) 1996-10-11 2005-04-13 The Regents of The University of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
US6231863B1 (en) * 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
PL337583A1 (en) 1997-06-30 2000-08-28 Rhone Poulenc Rorer Sa Improved method of transferring nucleic acid to a striated muscle and connection enabling accomplishment of this method
US6224882B1 (en) 1997-11-07 2001-05-01 Protein Science Corp. Insect cells or fractions as adjuvant for antigens
US6541458B1 (en) * 1999-07-16 2003-04-01 Merial Feline calicivirus genes and vaccines in particular recombinant vaccines
US6534066B1 (en) 1999-07-16 2003-03-18 Merial Inactivated vaccine against feline calicivirosis
US7850978B2 (en) * 1999-07-16 2010-12-14 Merial Limited Vaccine against feline calicivirus
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
WO2005080416A1 (en) * 2004-01-20 2005-09-01 Pharmacia & Upjohn Company Llc Feline calicivirus vaccines
KR20080025197A (ko) * 2005-07-28 2008-03-19 화이자 프로덕츠 인코포레이티드 백신 투여 방법, 새로운 고양이 칼리시바이러스, 및 고양이파보바이러스 및 고양이 헤르페스 바이러스에 대한 동물을면역화시키기 위한 처리

Also Published As

Publication number Publication date
MX380019B (es) 2025-03-11
NZ740551A (en) 2019-10-25
EP3337503A1 (en) 2018-06-27
MA42653A (fr) 2018-06-27
AU2016308630B2 (en) 2019-09-19
AU2016308630A1 (en) 2018-04-05
UY36860A (es) 2017-03-31
PH12018500372B1 (en) 2023-03-15
US10434165B2 (en) 2019-10-08
KR20180041724A (ko) 2018-04-24
MX2018002112A (es) 2019-03-28
CA2996143A1 (en) 2017-02-23
WO2017031120A1 (en) 2017-02-23
PH12018500372A1 (en) 2018-08-29
US20180243399A1 (en) 2018-08-30
CN108135997A (zh) 2018-06-08

Similar Documents

Publication Publication Date Title
MX2017003712A (es) Vacunas recombinantes contra fmdv y sus usos.
NZ602278A (en) Bluetongue virus recombinant vaccines and uses thereof
DOP2024000040A (es) Vacunas para vhb y métodos de tratamiento de vhb
AR133161A2 (es) Vacunas de partículas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos
UY36995A (es) Proteínas de fusión de e2 y fmdv y sus usos
MX2017004780A (es) Nuevos peptidos inmunogenos.
JOP20170022B1 (ar) لقاحات التهاب العين الفيروسي المهجنة المنقولة بواسطة اف ام دي في و استخداماتها
MX2011005604A (es) Vacuna recombinante para influenza aviar y sus usos.
EA201800494A1 (ru) Вакцины против химерного цирковируса свиней типа 2 (pcv2)
EA202090049A1 (ru) Поксвирусные векторы, кодирующие антигены вич, и способы их применения
MX2022000222A (es) Vectores virales recombinantes que contienen la proteina menor del virus del sindrome reproductor y respiratorio porcino (prrsv) y sus metodos de elaboracion y uso.
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
AR105819A1 (es) Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos
MX2010008170A (es) Vacunas para influenza canina.
UY36328A (es) Vacunas de fmdv recombinante y usos de las mismas
Valenzuela Persico El aprendizaje permanente y la igualdad de oportunidades de género: un enfoque de justicia social
EA201992167A1 (ru) Вакцина
MX390292B (es) Vacuna heterologa atenuada viva para leptospira.

Legal Events

Date Code Title Description
FG Grant, registration